Trading a BBC straddle lets you take a pure volatility position on Virtus Biotech Clinical Trials ETF without committing to a direction. Virtus Biotech Clinical Trials ETF's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate BBC straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on BBC profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Virtus Biotech Clinical Trials ETF stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the BBC straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the BBC straddle is the cleanest expression of that view. Our scanner prices every BBC straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a BBC straddle into a catalyst or short a BBC straddle to harvest decay, the options straddle setups that matter are all in one place.
